IPRIPR2018-01710Final Written Decision
Eli Lilly and Companyv.Teva Pharmaceuticals International GmbH et al.
IPR challenge of US 8586045.
Type
IPR
Filed
Sep 28, 2018
Instituted
Apr 3, 2019
Decided
—
Patent
Application
13179846
Inventor
Joerg Zeller et al
Granted
Nov 19, 2013
01
Timeline
3 milestones
2018-09-28Petition filed
2019-04-03Institution
2020-03-31Terminated
02
Parties & counsel
Petitioner
Eli Lilly and Company
Counsel
Raich, Williamet al
Patent Owner
Teva Pharmaceuticals International GmbH et al.
Counsel
Sterling, Deborahet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →